Latest colitis Stories
One of the nation’s leading doctors is now offering to treat patients for life for one low fee instead of having to pay every time an appointment is scheduled. Ogunquit,
NEW YORK, Dec.
PTG-100, a Novel Peptide as an 'Oral Targeted Therapy' for Inflammatory Bowel Diseases MILPITAS, Calif., Dec.
CCFA highlights the now 1.6 million Americans with these autoimmune diseases with new social media campaign during Crohn's & Colitis Awareness Week December 1-7, 2014 NEW YORK, Dec.
One of the nation’s leading doctors has reached a new milestone while providing healing for thousands of patients over the past three decades. Ogunquit, Maine
MIAMI LAKES, Fla., Nov.
Tavish & Trevor Margers highlight 450 runners and walkers representing Team Challenge at the sixth annual Rock 'n' Roll Las Vegas Marathon & 1/2 Marathon. NEW YORK, Nov.
October’s cannabinoid science roundup on the Bryan William Brickner Blog highlights new National Institutes of Health (PubMed) research.
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
LA JOLLA, Calif., and JUPITER, Fla., Oct.
Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...
- Emitting flashes of light; glittering.